OTC: BWVI

Invest on Wefunder

Next-Generation Biotech Solutions

For Safer, More Effective Psychedelic Therapeutics

PSYCHECEUTICAL

Cutting-Edge Technologies for the Next Generation of Mental Health Treatment

We're removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds.

Our Vision

We believe psychedelics are the next major breakthrough in mental health treatment, but healthcare providers need safer, more controlled ways to treat patients.

Learn More

Our Tech

With two next-generation patented delivery technologies, we're striving to increase the safety & efficacy of psychedelic compounds for mental health treatment.

Our Solution

Our Team

Our visionary team brings 100+ years of combined experience in psychedelics, biotechnology, and business development across the pharmaceutical industry.

Meet The Team

Latest News & Press

PSYCHEDELIC SPOTLIGHT
November 8, 2023

Topical Ketamine: A Game-Changer for PTSD?

EXPRESS PHARMA
November 2023

Creating Non-habit Forming Formulations and Treatment Protocols for Psychedelic Substances is Crucial

PHARMACY TIMES
October 6, 2023

Topical Ketamine: A Promising New Avenue for PTSD Treatment

PRESS RELEASE
August 10, 2023

Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect™ Ketamine for PTSD

FREETHINK.COM
July 25, 2023

New Clinical Trial is Testing a Ketamine Skin Cream for PTSD; The Hope is That It’ll Deliver the Benefits of the Drug — Without Causing Hallucinations.

CLINICAL TRIALS ARENA
July 14, 2023

OTC: BWVI

Invest on Wefunder

Next-Generation Biotech Solutions

For Safer, More Effective Psychedelic Therapeutics

PSYCHECEUTICAL

Cutting-Edge Technologies for the Next Generation of Mental Health Treatment

We're removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds.

Our Vision

We believe psychedelics are the next major breakthrough in mental health treatment, but healthcare providers need safer, more controlled ways to treat patients.

Our Tech

With two next-generation patented delivery technologies, we're striving to increase the safety & efficacy of psychedelic compounds for mental health treatment.

Our Team

Our visionary team brings 100+ years of combined experience in psychedelics, biotechnology, and business development across the pharmaceutical industry.

Latest News & Press

Topical Ketamine: A Game-Changer for PTSD?

READ MORE

Creating Non-habit Forming Formulations and Treatment Protocols for Psychedelic Substances is Crucial

READ MORE

Topical Ketamine: A Promising New Avenue for PTSD Treatment

READ MORE

Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect™ Ketamine for PTSD

READ MORE

New Clinical Trial is Testing a Ketamine Skin Cream for PTSD; The Hope is That It’ll Deliver the Benefits of the Drug — Without Causing Hallucinations.

READ MORE

Psycheceutical Starts a Phase I Trial With Topical Ketamine; Prepares for a Phase II Trial With PTSD Patients to Test Neurodirect Topical Ketamine.

READ MORE

In the Press

Psycheceutical Bioscience, Inc. (OTC: BWVI) is developing cutting-edge technologies to advance the safe and effective delivery of psychedelic pharmaceutical medicines.

OTC: BWVI

Next-Generation Biotech Solutions

For Safer, More Effective Psychedelic Therapeutics

PSYCHECEUTICAL

Cutting-Edge Technologies for the Next Generation of Mental Health Treatment

We're removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds.

Our Vision

We believe psychedelics are the next major breakthrough in mental health treatment, but healthcare providers need safer, more controlled ways to treat patients.

Our Tech

With two next-generation patented delivery technologies, we're striving to increase the safety & efficacy of psychedelic compounds for mental health treatment.

Our Team

Our visionary team brings 100+ years of combined experience in psychedelics, biotechnology, and business development across the pharmaceutical industry.

Latest News & Press

In the Press

SUBSCRIBE FOR EMAIL UPDATES:

Psycheceutical Bioscience, Inc. (OTC: BWVI) is developing cutting-edge technologies to advance the safe and effective delivery of psychedelic pharmaceutical medicines.

GET EMAIL UPDATES FROM PSYCHECEUTICAL, INC.